Pediatrix Medical Group, Inc. Quarterly Operating Income (Loss) in USD from Q1 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pediatrix Medical Group, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q4 2024.
  • Pediatrix Medical Group, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was $39.3M.
  • Pediatrix Medical Group, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$68.7M, a 1039% decline year-over-year.
  • Pediatrix Medical Group, Inc. annual Operating Income (Loss) for 2024 was -$68.7M, a 1039% decline from 2023.
  • Pediatrix Medical Group, Inc. annual Operating Income (Loss) for 2023 was $7.32M, a 95.8% decline from 2022.
  • Pediatrix Medical Group, Inc. annual Operating Income (Loss) for 2022 was $173M, a 14.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$68.7M $39.3M +$151M Oct 1, 2024 Dec 31, 2024 10-K 2025-02-20
Q3 2024 -$219M $33.8M -$6.45M -16% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-01
Q2 2024 -$213M -$158M -$206M -425% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$6.83M $15.9M -$14.1M -47.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $7.32M -$111M -$148M -409% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-20
Q3 2023 $155M $40.3M -$7.12M -15% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-01
Q2 2023 $162M $48.5M -$1.66M -3.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $164M $30M -$9.07M -23.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $173M $36M -$32M -47% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-20
Q3 2022 $205M $47.4M -$11.4M -19.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $216M $50.2M +$139K +0.28% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $216M $39.1M +$13M +49.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $203M $68M +$35.7M +111% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $167M $58.8M +$38.3M +187% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $129M $50M +$15.5M +44.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $113M $26.1M +$15.3M +142% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $98.1M $32.3M -$7.84M -19.5% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-18
Q3 2020 $106M $20.5M -$28.1M -57.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $134M $34.6M -$8.49M -19.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $143M $10.8M -$29.2M -73% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $172M $40.1M -$65.4M -62% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-18
Q3 2019 $237M $48.6M -$55.6M -53.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-18
Q2 2019 $293M $43.1M -$79.3M -64.8% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-18
Q1 2019 $372M $40M -$59.7M -59.9% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-18
Q4 2018 $432M $106M -$20.2M -16% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 $452M $104M -$22.2M -17.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-20
Q2 2018 $474M $122M +$489K +0.4% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-20
Q1 2018 $474M $99.7M -$6.37M -6.01% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-20
Q4 2017 $480M $126M -$17.1M -12% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-14
Q3 2017 $497M $126M -$30.5M -19.4% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-14
Q2 2017 $528M $122M -$25.9M -17.5% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-14
Q1 2017 $553M $106M -$18.2M -14.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-14
Q4 2016 $572M $143M -$8.18M -5.42% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-14
Q3 2016 $580M $157M +$5.76M +3.81% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-14
Q2 2016 $574M $148M +$6.83M +4.84% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-14
Q1 2016 $567M $124M +$9.41M +8.2% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-14
Q4 2015 $558M $151M +$9.87M +7% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-10
Q3 2015 $548M $151M +$13M +9.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-10
Q2 2015 $535M $141M +$11.3M +8.7% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-10
Q1 2015 $524M $115M +$10.7M +10.3% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-10
Q4 2014 $513M $141M +$17.2M +13.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-11
Q3 2014 $496M $138M +$14.9M +12% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-11
Q2 2014 $481M $130M +$16.3M +14.4% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-11
Q1 2014 $465M $104M +$12.5M +13.7% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-11
Q4 2013 $452M $124M +$20.9M +20.3% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-09
Q3 2013 $431M $123M +$15.9M +14.8% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-09
Q2 2013 $415M $113M +$13.6M +13.7% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-09
Q1 2013 $402M $91.6M +$12.2M +15.3% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-09
Q4 2012 $390M $103M +$11.5M +12.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-12
Q3 2012 $378M $107M +$12.3M +13% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-12
Q2 2012 $366M $99.7M +$6.61M +7.1% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-12
Q1 2012 $359M $79.4M +$3.67M +4.84% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-12
Q4 2011 $355M $91.5M +$5.62M +6.55% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-15
Q3 2011 $350M $95M +$13.7M +16.8% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-15
Q2 2011 $336M $93.1M +$11M +13.4% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-15
Q1 2011 $325M $75.7M +$12.2M +19.1% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-15
Q4 2010 $313M $85.9M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-29
Q3 2010 $81.4M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-29
Q2 2010 $82.1M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-29
Q1 2010 $63.6M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.